Belpointe Asset Management LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,979 shares of the healthcare product maker’s stock after purchasing an […]
Belpointe Asset Management LLC boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 26,979 shares of the healthcare product maker’s stock after purchasing an additional 232 shares during the period. Belpointe Asset […]
Rhenman & Partners Asset Management AB reduced its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 21.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 205,000 shares of the healthcare product maker’s stock after selling 56,675 shares during […]
Keb Asset Management LLC boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 12.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,584 shares of the healthcare product maker’s stock after buying an additional 403 […]
Evoke Wealth LLC grew its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,218 shares of the healthcare product maker’s stock after acquiring an additional 626 shares during the quarter. Evoke Wealth LLC’s […]